Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 43, 2013 - Issue 10
611
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Dissecting the relative contribution of OATP1B1-mediated uptake of xenobiotics into human hepatocytes using siRNA

, , , , &
Pages 920-931 | Received 09 Jan 2013, Accepted 11 Feb 2013, Published online: 06 Mar 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Ravindra V. Alluri, Rui Li & Manthena V. S. Varma. (2020) Transporter–enzyme interplay and the hepatic drug clearance: what have we learned so far?. Expert Opinion on Drug Metabolism & Toxicology 16:5, pages 387-401.
Read now
Adam J. Lucas, Joanne L. Sproston, Patrick Barton & Robert J. Riley. (2019) Estimating human ADME properties, pharmacokinetic parameters and likely clinical dose in drug discovery. Expert Opinion on Drug Discovery 14:12, pages 1313-1327.
Read now
Sumathy Mathialagan, Chester Costales, Laurie Tylaska, Emi Kimoto, Anna Vildhede, Jillian Johnson, Nathaniel Johnson, Takami Sarashina, Kenta Hashizume, Caleb D. Isringhausen, Lydia M. M. Vermeer, Andrea R. Wolff & A. David Rodrigues. (2018) In vitro studies with two human organic anion transporters: OAT2 and OAT7. Xenobiotica 48:10, pages 1037-1049.
Read now
Beth Williamson & Robert J. Riley. (2017) Hepatic transporter drug-drug interactions: an evaluation of approaches and methodologies. Expert Opinion on Drug Metabolism & Toxicology 13:12, pages 1237-1250.
Read now
M. Neary & A. Owen. (2017) Pharmacogenetic considerations for HIV treatment in different ethnicities: an update. Expert Opinion on Drug Metabolism & Toxicology 13:11, pages 1169-1181.
Read now
R. J. Riley, S. A. Foley, P. Barton, M. G. Soars & B. Williamson. (2016) Hepatic drug transporters: the journey so far. Expert Opinion on Drug Metabolism & Toxicology 12:2, pages 201-216.
Read now
Fen Chen, Xuejia Zhai, Chaoran Zhu & Yongning Lu. (2015) Effects of capsaicin on pharmacokinetics of pitavastatin in rats. Xenobiotica 45:2, pages 171-176.
Read now

Articles from other publishers (21)

Kazuya Maeda & Yuichi Sugiyama. 2022. Drug Transporters. Drug Transporters 453 474 .
Daiki Mori, Emi Kimoto, Brian Rago, Yusuke Kondo, Amanda King‐Ahmad, Ragu Ramanathan, Linda S. Wood, Jillian G. Johnson, Vu H. Le, Manoli Vourvahis, A. David Rodrigues, Chieko Muto, Kenichi Furihata, Yuichi Sugiyama & Hiroyuki Kusuhara. (2020) Dose‐Dependent Inhibition of OATP1B by Rifampicin in Healthy Volunteers: Comprehensive Evaluation of Candidate Biomarkers and OATP1B Probe Drugs. Clinical Pharmacology & Therapeutics 107:4, pages 1004-1013.
Crossref
Emi Kimoto, R. Scott Obach & Manthena V.S. Varma. (2020) Identification and quantitation of enzyme and transporter contributions to hepatic clearance for the assessment of potential drug-drug interactions. Drug Metabolism and Pharmacokinetics 35:1, pages 18-29.
Crossref
Yoshitane Nozaki & Saki Izumi. (2020) Recent advances in preclinical in vitro approaches towards quantitative prediction of hepatic clearance and drug-drug interactions involving organic anion transporting polypeptide (OATP) 1B transporters. Drug Metabolism and Pharmacokinetics 35:1, pages 56-70.
Crossref
Rui Li. (2019) Estimating In Vivo Fractional Contribution of OATP1B1 to Human Hepatic Active Uptake by Mechanistically Modeling Pharmacogenetic Data. The AAPS Journal 21:4.
Crossref
Yi-an Bi, Chester Costales, Sumathy Mathialagan, Mark West, Soraya Eatemadpour, Sarah Lazzaro, Laurie Tylaska, Renato Scialis, Hui Zhang, John Umland, Emi Kimoto, David A. Tess, Bo Feng, Larry M. Tremaine, Manthena V. S. Varma & A. David Rodrigues. (2019) Quantitative Contribution of Six Major Transporters to the Hepatic Uptake of Drugs: “SLC-Phenotyping” Using Primary Human Hepatocytes. Journal of Pharmacology and Experimental Therapeutics 370:1, pages 72-83.
Crossref
Yueping Zhang, Erika Panfen, Marcus Fancher, Michael Sinz, Punit Marathe & Hong Shen. (2019) Dissecting the Contribution of OATP1B1 to Hepatic Uptake of Statins Using the OATP1B1 Selective Inhibitor Estropipate. Molecular Pharmaceutics 16:6, pages 2342-2353.
Crossref
Pallabi Mitra, Samantha Weinheimer, Meeghan Michalewicz & Mitchell E. Taub. (2018) Prediction and Quantification of Hepatic Transporter-Mediated Uptake of Pitavastatin Utilizing a Combination of the Relative Activity Factor Approach and Mechanistic Modeling. Drug Metabolism and Disposition 46:7, pages 953-963.
Crossref
Saki Izumi, Yoshitane Nozaki, Hiroyuki Kusuhara, Koichiro Hotta, Toshiki Mochizuki, Takafumi Komori, Kazuya Maeda & Yuichi Sugiyama. (2018) Relative Activity Factor (RAF)-Based Scaling of Uptake Clearance Mediated by Organic Anion Transporting Polypeptide (OATP) 1B1 and OATP1B3 in Human Hepatocytes. Molecular Pharmaceutics 15:6, pages 2277-2288.
Crossref
Houfu Liu & Jasminder Sahi. (2016) Role of Hepatic Drug Transporters in Drug Development. The Journal of Clinical Pharmacology 56, pages S11-S22.
Crossref
William Brian, Larry M Tremaine, Million Arefayene, Ruben de Kanter, Raymond Evers, Yingying Guo, James Kalabus, Wen Lin, Cho-Ming Loi & Guangqing Xiao. (2016) Assessment of drug metabolism enzyme and transporter pharmacogenetics in drug discovery and early development: perspectives of the I-PWG. Pharmacogenomics 17:6, pages 615-631.
Crossref
A. Vildhede, A. Mateus, E. K. Khan, Y. Lai, M. Karlgren, P. Artursson & M. C. Kjellsson. (2016) Mechanistic Modeling of Pitavastatin Disposition in Sandwich-Cultured Human Hepatocytes: A Proteomics-Informed Bottom-Up Approach. Drug Metabolism and Disposition 44:4, pages 505-516.
Crossref
Kyunghee Yang, Cen Guo, Jeffrey L. Woodhead, Robert L. St. ClaireIIIIII, Paul B. Watkins, Scott Q. Siler, Brett A. Howell & Kim L.R. Brouwer. (2016) Sandwich-Cultured Hepatocytes as a Tool to Study Drug Disposition and Drug-Induced Liver Injury. Journal of Pharmaceutical Sciences 105:2, pages 443-459.
Crossref
Magnus Ölander, Jacek R. Wiśniewski, Pär Matsson, Patrik Lundquist & Per Artursson. (2016) The Proteome of Filter-Grown Caco-2 Cells With a Focus on Proteins Involved in Drug Disposition. Journal of Pharmaceutical Sciences 105:2, pages 817-827.
Crossref
Stefanie Hennig, Suhashni Naiker, Tarylee Reddy, Deirdre Egan, Tracy Kellerman, Lubbe Wiesner, Andrew Owen, Helen McIlleron & Alexander Pym. (2016) Effect of SLCO1B1 Polymorphisms on Rifabutin Pharmacokinetics in African HIV-Infected Patients with Tuberculosis . Antimicrobial Agents and Chemotherapy 60:1, pages 617-620.
Crossref
Donald R.J. Singer & Zoulikha M. Zaïr. 2016. Personalized Medicine. Personalized Medicine 79 114 .
Annett Kunze, Jörg Huwyler, Gian Camenisch & Birk Poller. (2014) Prediction of Organic Anion-Transporting Polypeptide 1B1- and 1B3-Mediated Hepatic Uptake of Statins Based on Transporter Protein Expression and Activity Data. Drug Metabolism and Disposition 42:9, pages 1514-1521.
Crossref
Laurent Salphati, Xiaoyan Chu, Liangfu Chen, Bhagwat Prasad, Shannon Dallas, Raymond Evers, Donna Mamaril-Fishman, Ethan G. Geier, Jonathan Kehler, Jeevan Kunta, Mario Mezler, Loic Laplanche, Jodie Pang, Anja Rode, Matthew G. Soars, Jashvant D. Unadkat, Robert A. B. van Waterschoot, Jocelyn Yabut, Alfred H. Schinkel & Nico Scheer. (2014) Evaluation of Organic Anion Transporting Polypeptide 1B1 and 1B3 Humanized Mice as a Translational Model to Study the Pharmacokinetics of Statins. Drug Metabolism and Disposition 42:8, pages 1301-1313.
Crossref
Rui Li, Hugh A. Barton & Manthena V. Varma. (2014) Prediction of Pharmacokinetics and Drug–Drug Interactions When Hepatic Transporters are Involved. Clinical Pharmacokinetics 53:8, pages 659-678.
Crossref
Etienne P. A. Neve, Per Artursson, Magnus Ingelman-Sundberg & Maria Karlgren. (2013) An Integrated in Vitro Model for Simultaneous Assessment of Drug Uptake, Metabolism, and Efflux . Molecular Pharmaceutics 10:8, pages 3152-3163.
Crossref
Kazuya Maeda & Yuichi Sugiyama. 2013. Transporters in Drug Development. Transporters in Drug Development 121 153 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.